Food and Drug Administration FDA has granted accelerated approval to olaparib Lynparza for women with advanced ovarian cancer with deleterious or suspected deleterious germline BRCA mutated advanced ovarian cancer, as detected by an FDA approved test, who have been treated with three http://zithromax.top>is azithromycin a penicillin the patient will need frequent eye examinations